Acamprosate promotes abstinence in alcohol-dependent patients who relapse during treatment

被引：0
作者：
Schneider, E [1 ]
Saikali, K [1 ]
Zhang, DZ [1 ]
Gage, A [1 ]
机构：
[1] Forest Labs Inc, New York, NY USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2005年 / 29卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：160A / 160A
页数：1
相关论文
共 50 条
  • [1] Efficacy of acamprosate in regaining abstinence in alcohol-dependent patients who relapse
    Schneider, Eugene
    Saikali, K.
    Zhang, D.
    Gage, A.
    AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (04) : 319 - 319
  • [2] Acamprosate decreases the severity and duration of relapse and aids in post-relapse recovery of abstinence in alcohol-dependent patients
    Schneider, E.
    Saikali, K.
    Zhang, D.
    Gage, A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (06) : 107A - 107A
  • [3] Acamprosate facilitates the maintenance of abstinence in alcohol-dependent patients after alcohol withdrawal
    不详
    Drugs & Therapy Perspectives, 2006, 22 (3) : 1 - 4
  • [4] Economic costs of acamprosate treatment among alcohol-dependent patients initiating an abstinence program
    Erder, MH
    Weycker, D
    Oster, G
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 172A - 172A
  • [5] Economic evaluation of Campral® (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients
    Annemans, L
    Vanoverbeke, N
    Tecco, J
    D'Hooghe, D
    EUROPEAN ADDICTION RESEARCH, 2000, 6 (02) : 71 - 78
  • [6] A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients
    Weinstein, A
    Feldtkeller, B
    Feeney, A
    Lingford-Hughes, A
    Nutt, DJ
    ADDICTION BIOLOGY, 2003, 8 (02) : 229 - 232
  • [7] Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence
    Boeijinga, PH
    Parot, P
    Soufflet, L
    Landron, F
    Danel, T
    Gendre, I
    Muzet, M
    Demazières, A
    Luthringer, R
    NEUROPSYCHOBIOLOGY, 2004, 50 (01) : 71 - 77
  • [8] Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
    Karpyak, V. M.
    Biernacka, J. M.
    Geske, J. R.
    Jenkins, G. D.
    Cunningham, J. M.
    Rueegg, J.
    Kononenko, O.
    Leontovich, A. A.
    Abulseoud, O. A.
    Hall-Flavin, D. K.
    Loukianova, L. L.
    Schneekloth, T. D.
    Skime, M. K.
    Frank, J.
    Noethen, M. M.
    Rietschel, M.
    Kiefer, F.
    Mann, K. F.
    Weinshilboum, R. M.
    Frye, M. A.
    Choi, D. S.
    TRANSLATIONAL PSYCHIATRY, 2014, 4 : e462 - e453
  • [9] Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate
    V M Karpyak
    J M Biernacka
    J R Geske
    G D Jenkins
    J M Cunningham
    J Rüegg
    O Kononenko
    A A Leontovich
    O A Abulseoud
    D K Hall-Flavin
    L L Loukianova
    T D Schneekloth
    M K Skime
    J Frank
    M M Nöthen
    M Rietschel
    F Kiefer
    K F Mann
    R M Weinshilboum
    M A Frye
    D S Choi
    Translational Psychiatry, 2014, 4 : e453 - e453
  • [10] Treatment of alcohol-dependent outpatients with acamprosate: A clinical review
    Mason, BJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 42 - 48
12345